Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

MicroRNAs01:22

MicroRNAs

3.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

360
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
360
Riboswitches01:56

Riboswitches

8.7K
Riboswitches are non-coding mRNA domains that regulate the transcription and translation of downstream genes without the help of proteins. Riboswitches bind directly to a metabolite and can form unique stem-loop or hairpin structures in response to the amount of the metabolite present. They have two distinct regions – a metabolite-binding aptamer and an expression platform.
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
8.7K
Experimental RNAi02:15

Experimental RNAi

6.3K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.3K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Comparative Analysis of Meat Quality and Muscle Transcriptome between Landrace and Jeju Native Pig.

Food science of animal resources·2026
Same author

Glutamate excreted by LepR⁺ BM-MSCs mitigates alcohol-associated liver disease by promoting IL-1R2⁺ monocyte migration.

Clinical and molecular hepatology·2026
Same author

Polyhydroxyalkanoate-Based Microparticles for Enhanced Photostability and Controlled Release of Pyraclostrobin.

Polymers·2026
Same author

Longitudinal profiling reveals immune dynamics and distinct plasma cell signatures during B-cell depletion in IgG4-related disease.

Annals of the rheumatic diseases·2026
Same author

Phenylalanyl-tRNA synthetase FARS-1/FARSA balances longevity and immunity by downregulating endogenous mitochondrial double-stranded RNAs.

Molecular cell·2026
Same author

Self-amplifying CRISPR-based one-pot ultrasensitive testing for rapid SARS-CoV-2 and its variant detection.

Biosensors & bioelectronics·2026
Same journal

Engineering graphene oxide interfaces for electrochemical biosensing of biomolecules, cells, and organoids.

Nano convergence·2026
Same journal

Laser-irradiated coffee waste: a path to eco-friendly anode materials for lithium-ion batteries.

Nano convergence·2026
Same journal

Synergistic photothermal and magnetothermal heat generation with Sc-doped iron oxide nanoflakes: a platform for potential bimodal tumor therapy.

Nano convergence·2026
Same journal

2D MoS<sub>2</sub>-conformal 3D-printed platform for dual-phototherapy and bone regeneration.

Nano convergence·2026
Same journal

High-throughput discovery of Li<sub>3</sub>Sc<sub>2</sub>(PO<sub>4</sub>)<sub>3</sub> as a protective coating for stabilizing mid-Ni NCM interfaces in all-solid-state batteries.

Nano convergence·2026
Same journal

Optimization strategies for crystal orientation in antimony-based chalcogenide thin-film solar cells.

Nano convergence·2026
查看所有相关文章

相关实验视频

Updated: Sep 17, 2025

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

5.7K

使用工程化miRNA响应性寡核酸的自我调节治疗平台.

Doyeong Ku1, Hansol Kim1, JinA Lim1

  • 1Department of Chemical and Biomolecular Engineering (BK 21+ Program), Korea Advanced Institute of Science and Technology (KAIST), Daejeon, 34141, Republic of Korea.

Nano convergence
|June 30, 2025
PubMed
概括
此摘要是机器生成的。

研究人员开发了一种新的miRNA触发器寡核酸,可以选择性地降低疾病相关的microRNAs (miRNAs). 这种方法针对抗亡基因,诱导癌细胞亡并减少体内瘤体积,建立了一个新的治疗平台.

关键词:
诱导亡的诱导亡.这就是BCL-xL基因.基因调节 基因调节橄核酸治疗方法这就是miRNAs.

更多相关视频

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
06:51

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents

Published on: August 10, 2018

7.8K
A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA
06:53

A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA

Published on: December 26, 2015

12.8K

相关实验视频

Last Updated: Sep 17, 2025

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

5.7K
Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
06:51

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents

Published on: August 10, 2018

7.8K
A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA
06:53

A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA

Published on: December 26, 2015

12.8K

科学领域:

  • 分子生物学分子生物学
  • 氧核酸治疗药物 治疗药物
  • 癌症研究 癌症研究

背景情况:

  • 微RNAs (miRNAs) 在转录后基因调节中至关重要,并与各种疾病有关.
  • 由于其在疾病发病过程中的作用,miRNAs被认为是潜在的生物标志物和治疗点.
  • 目前针对miRNAs的治疗策略有限.

研究的目的:

  • 引入一种名为miRNA触发器的新型寡核酸探针,用于选择性miRNA介导的基因下调.
  • 设计miRNA触发器以准特定的与疾病相关的miRNA及其下游影响.
  • 评估miRNA触发剂在癌症治疗中的治疗潜力.

主要方法:

  • 设计和合成miRNA触发性寡核酸.
  • 工程miRNA触发器专门绑定和劫持目标miRNAs.
  • 在癌细胞中证明了选择性mRNA下调和亡诱导.
  • 在异种移植小鼠模型中对治疗疗效的体内验证.

主要成果:

  • 开发的miRNA触发器通过劫持特定的miRNA选择性地降低了目标mRNA的调节.
  • 工程化miRNA触发器诱导了乳腺癌细胞过度表达特定miRNA的亡.
  • 在体内给予miRNA触发剂显著降低了异种移植小鼠的瘤体积.
  • 这种方法证明了成功的治疗疗效和瘤减少.

结论:

  • miRNA触发器通过重定向与疾病相关的miRNAs来为寡核酸治疗提供了一个新的平台.
  • 这项技术可以通过miRNA调制来实现向基因沉默.
  • 这些发现支持miRNA触发器作为miRNA相关疾病,特别是癌症的新治疗策略的潜力.